In patients with severe retinopathy of prematurity, intravitreal anti-VEGF injection only preserves significant peripheral vision compared with laser treatment, according to a presentation at the 2020 ASRS Virtual Meeting.
In this study, 6 eyes with retinopathy of prematurity were treated with laser and 12 eyes were treated with intravitreal anti-VEGF injection only. Standard automated perimetry was performed on all patients at 10 years old.
In both groups, regression of disease was seen after treatment. At 10 years old, patients in the laser-treated group had a significantly restricted visual field area compared to those in the anti-VEGF injection only treatment group.
Banker AS, et al. Results of perimetry at age of 10 years in severe ROP eyes receiving laser or anti-VEGF treatment as primary monotherapy. Presented at: 2020 ASRS Virtual Meeting.